In HIV infection, the latent cells represent a reservoir that contributes to the failure of the Highly Active Anti-Retroviral Therapy (HAART). This fact requires investigating the possible strategy to improve the administration of the HAART therapy, in order to guarantee the control of the virus load to the lost level as long as possible. In this work, we aim to study the possibility of reducing the latent infected CD4+ reservoir in the HIV infection by considering a mathematical model of two types of latently infected CD4+: fast and slow, and eight virus strains: wild-type, three single mutants, three double mutants and a fully resistant triple mutant. The HAART therapy is considered as an optimal control problem that aimes to reduce the...
The purpose of this paper is to expose the optimal approach of controlling HIV-1 infection in CD4+T ...
Abstract: Here is presented an application of Optimal Control to a model describing the dynamics of ...
Of great concern today is the treatment of patients infected with the human immunodeficiency virus (...
In HIV infection, the latent cells represent a reservoir that contributes to the failure of the High...
In HIV infection, the latent cells represent a reservoir that contribute to the of failure of the Hi...
Latently infected CD 4 + T cells represent one of the major obstacles to HIV eradication even after ...
HIV-1 infection typically involves a long clinical latency stage during which CD4 counts decline slo...
Human immunodeficiency virus infection destroys the body immune system, increases the risk of certai...
Human immunodeficiency virus infection destroys the body immune system, increases the risk of certai...
The main goal of this study was to develop a theoretical short- and long-term optimal control treatm...
Objectives: To investigate factors that may influence the success or failure of powerful antiretrovi...
Antiretroviral therapy is able to suppress the viral load below the detection limit, but it is not a...
A mathematical model for the transmission dynamics of human immunodeficiency virus (HIV) within a ho...
In this project, we study the dynamics of HIV under gene therapy and latency reversing agents. For c...
A very important scientific advance was the identification of HIV as a causative agent for AIDS. HI...
The purpose of this paper is to expose the optimal approach of controlling HIV-1 infection in CD4+T ...
Abstract: Here is presented an application of Optimal Control to a model describing the dynamics of ...
Of great concern today is the treatment of patients infected with the human immunodeficiency virus (...
In HIV infection, the latent cells represent a reservoir that contributes to the failure of the High...
In HIV infection, the latent cells represent a reservoir that contribute to the of failure of the Hi...
Latently infected CD 4 + T cells represent one of the major obstacles to HIV eradication even after ...
HIV-1 infection typically involves a long clinical latency stage during which CD4 counts decline slo...
Human immunodeficiency virus infection destroys the body immune system, increases the risk of certai...
Human immunodeficiency virus infection destroys the body immune system, increases the risk of certai...
The main goal of this study was to develop a theoretical short- and long-term optimal control treatm...
Objectives: To investigate factors that may influence the success or failure of powerful antiretrovi...
Antiretroviral therapy is able to suppress the viral load below the detection limit, but it is not a...
A mathematical model for the transmission dynamics of human immunodeficiency virus (HIV) within a ho...
In this project, we study the dynamics of HIV under gene therapy and latency reversing agents. For c...
A very important scientific advance was the identification of HIV as a causative agent for AIDS. HI...
The purpose of this paper is to expose the optimal approach of controlling HIV-1 infection in CD4+T ...
Abstract: Here is presented an application of Optimal Control to a model describing the dynamics of ...
Of great concern today is the treatment of patients infected with the human immunodeficiency virus (...